Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Do not increase the dose without getting a go-ahead from your healthcare provider
These tablets feature precise dosage, robust packaging, and stability at room temperature, making them an optimal choice for everyday adult use
These medications represent a significant advancement in obesity pharmacotherapy, with clinical trials demonstrating substantial weight loss benefits
GIP was initially isolated from intestinal extracts and shown to have a potent insulinotropic effect.10, 15, 16 However, clinical studies demonstrated that, in hyperglycemic states, the insulinotropic action of GIP is inhibited, while GLP-1s function remains intact.17, 18 Recent research indicates that GIP is largely responsible for postprandial insulin secretion in T2DM, rather than the opposite.19 In preclinical studies, GIP receptor deficiency in mice leads to impaired glucose tolerance with reduced -cell function,20 while GIP-overexpressing mice demonstrate reduced diet-induced obesity and steatosis, and improved beta cell function and glucose homeostasis.21 Collectively, GLP-1 and GIP seem to work in tandem with GLP-1 inhibiting glucagon secretion when the plasma glucose concentration is high, while GIP acts at lower glucose levels.17, 22 Thus, these two hormones could work together in T2DM as the consistent glucose-lowering effect of GLP-1 could potentiate the role of GIP, whose action is dependent upon the glycemic status
